Amrutanjan Health Care Ltd
AMRUTANJANAmrutanjan Health Care Ltd
AMRUTANJAN
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 52.64 | 7.77 | 0.59% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 52.29 | 6.68 | 0.47% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Amrutanjan Health Care Limited is engaged in offering ayurvedic balm for headaches, cold and cough. The Company operates through three segments: over-the-counter (OTC) products, beverages and others.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 190.11 | 214.14 | 227.88 | 260.36 | 269.80 | 344.16 | 421.22 | 394.18 | 437.58 | 444.22 | ||||||||||
Raw Materials | 64.86 | 85.69 | 94.01 | 122.16 | 124.05 | 135.18 | 185.96 | 183.71 | 209.67 | 378.91 | ||||||||||
| Power & Fuel Cost | 1.63 | 1.66 | 1.70 | 1.87 | 2.02 | 1.76 | 2.66 | 3.06 | 3.84 | |||||||||||
| Employee Cost | 28.01 | 29.67 | 33.85 | 33.36 | 39.36 | 41.70 | 48.23 | 48.81 | 47.69 | |||||||||||
| Selling & Administrative Expenses | 54.91 | 54.33 | 53.14 | 59.96 | 61.45 | 64.72 | 84.68 | 86.95 | 89.23 | |||||||||||
| Operating & Other expenses | 3.42 | 6.69 | 9.10 | 4.95 | 3.77 | 14.64 | 4.74 | 12.57 | 18.89 | |||||||||||
EBITDA | 37.28 | 36.10 | 36.08 | 38.06 | 39.15 | 86.16 | 94.95 | 59.08 | 68.26 | 65.31 | ||||||||||
| Depreciation/Amortization | 2.52 | 2.05 | 2.91 | 3.16 | 4.36 | 3.67 | 3.80 | 5.21 | 6.06 | 6.25 | ||||||||||
| PBIT | 34.76 | 34.05 | 33.17 | 34.90 | 34.79 | 82.49 | 91.15 | 53.87 | 62.20 | 59.06 | ||||||||||
| Interest & Other Items | 0.20 | 0.25 | 0.31 | 0.20 | 0.34 | 0.59 | 0.58 | 0.22 | 0.25 | 0.19 | ||||||||||
| PBT | 34.56 | 33.80 | 32.86 | 34.70 | 34.45 | 81.90 | 90.57 | 53.65 | 61.95 | 58.87 | ||||||||||
| Taxes & Other Items | 12.15 | 11.99 | 12.91 | 10.17 | 9.37 | 20.71 | 23.39 | 13.81 | 16.97 | 16.30 | ||||||||||
| Net Income | 22.41 | 21.81 | 19.95 | 24.53 | 25.08 | 61.19 | 67.18 | 39.84 | 44.98 | 42.57 | ||||||||||
| EPS | 7.67 | 7.46 | 6.83 | 8.39 | 8.58 | 20.93 | 22.98 | 13.63 | 15.47 | 14.72 | ||||||||||
| DPS | 1.93 | 1.93 | 1.53 | 2.15 | 2.10 | 4.20 | 4.60 | 4.60 | 4.60 | 4.60 | ||||||||||
| Payout ratio | 0.25 | 0.26 | 0.22 | 0.26 | 0.24 | 0.20 | 0.20 | 0.34 | 0.30 | 0.31 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Amrutanjan Health Care Ltd | 49.82 | 7.77 | 0.59% |
| Sun Pharmaceutical Industries Ltd | 47.65 | 6.80 | 0.71% |
| Cipla Ltd | 31.27 | 4.81 | 0.81% |
| Torrent Pharmaceuticals Ltd | 71.45 | 17.26 | 0.80% |
Price Comparison
Compare AMRUTANJAN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 3 Mutual Funds holding Amrutanjan Health Care Ltd
| Funds (Top 3) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
DSP Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 5.3398% | Percentage of the fund’s portfolio invested in the stock 0.72% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 57/84 (+2) |
ICICI Prudential FMCG Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.5740% | Percentage of the fund’s portfolio invested in the stock 3.06% | Change in the portfolio weight of the stock over the last 3 months 3.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 12/33 (+20) |
Sundaram Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.7646% | Percentage of the fund’s portfolio invested in the stock 1.10% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 25/100 (+2) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
AMRUTANJAN has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.59%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.93 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Dividend/Share
₹2.60
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateFeb 20, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Feb 20, 2024
Cash Dividend
Ex DateEx DateNov 23, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Nov 23, 2023
Cash Dividend
Ex DateEx DateSep 14, 2023
Dividend/Share
₹2.60
Ex DateEx Date
Sep 14, 2023
Cash Dividend
Ex DateEx DateFeb 24, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Feb 24, 2023
Amrutanjan Health Care announced that the 87th Annual General Meeting (AGM) of the company will be held on 23 September 2024.Powered by Capital Market - Live
Net profit of Amrutanjan Health Care declined 34.09% to Rs 4.62 crore in the quarter ended June 2024 as against Rs 7.01 crore during the previous quarter ended June 2023. Sales rose 7.55% to Rs 83.74 crore in the quarter ended June 2024 as against Rs 77.86 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales83.7477.86 8 OPM %4.249.17 - PBDT7.9410.81 -27 PBT6.359.42 -33 NP4.627.01 -34 Powered by Capital Market - Live
Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Mumbai-Pune Expressway: 2-hour Block on Part of Road on Tuesday, Traffic Snarls Likely | Here’s Why - News18
Deloitte finds malpractices in vendor management and casual labour onboarding by Amrutanjan employees
Amrutanjan Healthcare buyback: Should you tender your shares?
Amrutanjan Health Care board approves buyback plan at ₹900 per share
Amrutanjan Healthcare spikes 14% after buyback announcement. Check out details
Amrutanjan Health Care shares rally 12 per cent on buyback proposal
Stocks that will see action today (May 30, 2023)
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 10.94%, vs industry avg of 9.03%
Constant Market Share
Over the last 5 years, market share stayed at 0.12%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 12.89%, vs industry avg of 15.28%